Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Drug Manufacturers — Specialty and Generic

Catalent, Inc., together with its subsidiaries, provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products worldwide. It operates through four segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations. The Biologics segment provides biologic cell-line; develops and manufactures cell therapy and viral vector gene therapy; formulation, development, and manufacturing for parenteral dose forms, including prefilled syringes, vials, and cartridges; and analytical development and testing services. The Oral and Specialty Delivery segment offers formulation, development, and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. This segment also offers oral delivery solutions platform comprising pre-clinical screening, formulation, analytical development, and current good manufacturing practices services...
Website: catalent.com



Growth: Pretty weak revenue growth rate 4.2%, there is slowdown compared to average historical growth rates 17.9%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of +89.3%

Profitability: LTM EBITDA margin is negative, -12.2%. On average the margin is improving steadily. Gross margin is low, +17.7%. In the last quarter the company did not beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of -$0.03 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 4.7% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 99.2% higher than minimum and 14.5% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 1.6x by EV / Sales multiple , the company can be 6.3% overvalued

Key Financials (Download financials)

Ticker: CTLT
Share price, USD:  (0.0%)63.48
year average price 63.48  


year start price 63.48 2025-02-09

max close price 63.48 2025-02-09

min close price 63.48 2025-02-09

current price 63.48 2026-02-08
Common stocks: 179 212 982

Dividend Yield:  0.0%
EV / Sales: 1.7x
Margin (EBITDA LTM / Revenue): -12.2%
Fundamental value created in LTM:
Market Cap ($m): 11 376
Net Debt ($m): -287
EV (Enterprise Value): 11 089
Price to Book: 3.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2025-10-28businesswire.com

Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by “Championing the Missions that Matter™”

2025-10-11proactiveinvestors.com

Lisata Therapeutics CEO discusses Catalent deal - ICYMI

2025-06-06globenewswire.com

Asia-Pacific Pharmaceutical CMO Market Share Analysis, Trends and Growth Forecasts to 2030 Featuring Catalent, Recipharm, Jubilant Life Sciences and More

2025-04-15proactiveinvestors.com

Lisata Therapeutics signs research license with Catalent

2025-01-16reuters.com

Novo Holdings looks to double Catalent size with eye on Trump US manufacturing focus

2024-12-18reuters.com

Novo Holdings completes $16.5 bln takeover of Catalent

2024-12-14reuters.com

Regulatory conditions on Novo Holdings' $16.5 bln Catalent deal fulfilled, companies say

2024-12-14globenewswire.com

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

2024-12-14businesswire.com

Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction

2024-12-06businesswire.com

Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2 2020 q2
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30 2020-06-30
symbol CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-11-05 2024-05-08 2024-02-14 2023-12-08 2023-06-12 2023-02-07 2022-11-01
acceptedDate 2024-11-05 16:01:06 2024-10-25 16:41:33 2024-05-08 16:23:50 2024-02-14 14:23:55 2023-12-08 17:06:39 2023-12-08 17:05:20 2023-06-12 16:08:27 2023-02-07 09:26:06 2022-11-01 09:16:12 2023-06-12 15:58:53 2021-08-30 09:26:48 2020-08-31 16:28:27
calendarYear 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY FY
revenue 1 023M 4 381M 1 074M 1 024M 982M 4 276M 1 037M 1 149M 1 022M 4 828M 3 998M 3 094M
costOfRevenue 842M 3 428M 845M 853M 801M 3 216M 857M 762M 764M 3 188M 2 646M 2 111M
grossProfit 181M 953M 229M 171M 181M 1 060M 180M 387M 258M 1 640M 1 352M 983M
grossProfitRatio 0.177 0.213 0.167 0.184 0.174 0.337 0.252
researchAndDevelopmentExpenses 0 0 4M 4M 4M 18M 0 0 0 23M 21M 64M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 252M 935M 214M 180M 215M 831M 190M 226M 196M 844M 687M 578M
otherExpenses 0 767M -2M -3M -13M 6M 15M 23M 2M 41M 0 -8M
operatingExpenses 252M 1 702M 246M 187M 216M 987M 205M 249M 198M 885M 706M 578M
costAndExpenses 1 094M 5 130M 1 091M 1 040M 1 017M 4 203M 1 062M 1 011M 962M 4 073M 3 352M 2 689M
interestIncome 0 0 0 0 0 0 0 0 0 123M 110M 126M
interestExpense 60M 254M 65M 66M 58M 186M 51M 47M 32M 123M 110M 126M
depreciationAndAmortization 113M 489M 126M 121M 687M 422M 4M 101M 99M 378M 289M 254M
ebitda 56M -284M 107M 105M -48M 266M -21M 239M 159M 1 080M 1 114M 640M
ebitdaratio 0.055 0.1 0.103 -0.049 -0.02 0.208 0.156
operatingIncome -71M -749M -17M -16M -735M -137M -25M 138M 60M 349M 354M 144M
operatingIncomeRatio -0.069 -0.016 -0.016 -0.748 -0.024 0.12 0.059
totalOtherIncomeExpensesNet -46M -278M -4M -166M -713M -179M -257M -24M -57M -151M -113M -134M
incomeBeforeTax -117M -1 027M -86M -182M -806M -315M -282M 114M 3M 605M 715M 260M
incomeBeforeTaxRatio -0.114 -0.08 -0.178 -0.821 -0.272 0.099 0.003
incomeTaxExpense 12M 16M 15M 24M -91M -83M -55M 33M 3M 86M 130M 40M
netIncome -129M -1 043M -101M -206M -715M -232M -227M 81M 0 499M 585M 173M
netIncomeRatio -0.126 -0.094 -0.201 -0.728 -0.219 0.07 0
eps -0.71 -5.76 -0.55 -1.13 -3.95 -1.28 -1.25 0.45 0 2.74 3.15 1.15
epsdiluted -0.71 -0.55 -1.13 -3.95 -1.25 0.44 0
weightedAverageShsOut 182M 181M 182M 182M 181M 181M 181M 180M 180M 176M 168M 150M
weightedAverageShsOutDil 182M 181M 182M 182M 181M 181M 181M 184M 181M 178M 170M 152M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-10-25 2023-12-08 2023-06-12 2021-08-30 2020-08-31
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -254M -186M -127M -128M -142M
ebit -773M -156M 702M 825M 387M
nonOperatingIncomeExcludingInterest 24M -7M 28M 3M 8M
netIncomeFromContinuingOperations -1 043M -256M 499M 585M 221M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 -56M -48M
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -1 043M -256M 483M 529M 173M
epsDiluted -5.76 -1.28 2.71 3.11 1.14

Balance Sheet Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2 2020 q2
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30 2020-06-30
symbol CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-11-05 2024-05-08 2024-02-14 2023-12-08 2023-06-12 2023-02-07 2022-11-01
acceptedDate 2024-11-05 16:01:06 2024-10-25 16:41:33 2024-05-08 16:23:50 2024-02-14 14:23:55 2023-12-08 17:06:39 2023-12-08 17:05:20 2023-06-12 16:08:27 2023-02-07 09:26:06 2022-11-01 09:16:12 2023-06-12 15:58:53 2021-08-30 09:26:48 2020-08-31 16:28:27
calendarYear 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY FY
cashAndCashEquivalents 335M 289M 162M 229M 209M 280M 252M 442M 281M 449M 896M 953M
shortTermInvestments 0 0 0 0 0 0 0 28M 64M 89M 71M 0
cashAndShortTermInvestments 335M 289M 162M 229M 209M 280M 252M 470M 345M 538M 967M 953M
netReceivables 1 458M 1 566M 1 406M 1 366M 826M 1 439M 1 049M 1 450M 1 441M 1 497M 1 243M 919M
inventory 553M 574M 770M 775M 811M 764M 744M 841M 753M 702M 563M 324M
otherCurrentAssets 161M 77M 46M 200M 795M 66M 693M 59M 59M 92M 77M 54M
totalCurrentAssets 2 507M 2 597M 2 523M 2 570M 2 641M 2 679M 2 738M 2 918M 2 698M 2 916M 2 918M 2 293M
propertyPlantEquipmentNet 3 671M 3 720M 3 735M 3 777M 3 729M 3 699M 3 671M 3 579M 3 167M 3 127M 2 524M 1 901M
goodwill 2 366M 2 333M 2 339M 2 351M 2 316M 3 039M 3 023M 3 215M 2 929M 3 006M 2 519M 2 471M
intangibleAssets 811M 841M 875M 911M 3 676M 980M 1 012M 1 045M 1 017M 1 060M 817M 889M
goodwillAndIntangibleAssets 3 177M 3 174M 3 214M 3 262M 3 676M 4 019M 4 035M 4 260M 3 946M 4 066M 3 336M 3 359M
longTermInvestments 0 47M 85M 76M -3 776M -4 074M 0 0 0 33M 38M -3 409M
taxAssets 32M 7M 66M 55M 100M 55M 42M 55M 45M 49M 66M 49M
otherNonCurrentAssets 321M 208M 256M 248M 3 676M 4 404M 344M 335M 349M 316M 230M 3 583M
totalNonCurrentAssets 7 201M 7 156M 7 356M 7 418M 7 405M 8 103M 8 092M 8 229M 7 507M 7 591M 6 194M 5 484M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 9 708M 9 753M 9 879M 9 988M 10 046M 10 782M 10 830M 11 147M 10 205M 10 507M 9 112M 7 777M
accountPayables 375M 361M 377M 407M 367M 424M 394M 367M 379M 421M 385M 321M
shortTermDebt 61M 48M 57M 55M 624M 536M 588M 644M 119M 31M 75M 73M
taxPayables 6M 16M 14M 28M 44M 44M 23M 34M 42M 50M 30M 5M
deferredRevenue 272M 250M 249M 214M 179M 167M 203M 175M 135M 185M 305M 191M
otherCurrentLiabilities 284M 181M 324M 360M 373M 188M 302M 340M 310M 173M 201M 148M
totalCurrentLiabilities 998M 1 031M 1 007M 1 036M 1 543M 1 507M 1 487M 1 526M 943M 1 072M 1 196M 893M
longTermDebt 4 886M 4 857M 4 933M 4 959M 4 322M 4 313M 4 261M 4 221M 4 098M 4 171M 3 166M 2 817M
deferredRevenueNonCurrent 0 0 97M 5M -68M -76M 0 221M 214M 103M 195M 513M
deferredTaxLiabilitiesNonCurrent 0 5M 64M 50M 68M 76M 119M 221M 214M 197M 164M 94M
otherNonCurrentLiabilities 282M 256M 167M 251M 276M 247M 260M 46M 36M 182M 312M 1 074M
totalNonCurrentLiabilities 5 168M 5 118M 5 261M 5 265M 4 598M 4 640M 4 640M 4 709M 4 562M 4 640M 4 001M 3 985M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 13M 13M 10M 9M 4 322M 11M 11M 12M 13M 14M 16M 15M
totalLiabilities 6 166M 6 149M 6 268M 6 301M 6 141M 6 147M 6 127M 6 235M 5 505M 5 712M 5 197M 4 878M
preferredStock 0 0 0 1 055M 883M 24M 0 0 0 0 0 607M
commonStock 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
retainedEarnings -910M -781M -804M -703M -497M 262M 372M 619M 538M 538M 25M -535M
accumulatedOtherComprehensiveIncomeLoss -350M -404M -356M -354M -388M -354M -368M -395M -514M -394M -317M -386M
othertotalStockholdersEquity 4 800M 4 769M 3 687M 3 905M 4 697M 4 686M 4 674M
totalStockholdersEquity 3 542M 3 604M 3 611M 3 687M 3 905M 4 635M 4 703M 4 912M 4 700M 4 795M 3 915M 2 899M
totalEquity 3 542M 3 604M 3 611M 3 687M 3 905M 4 635M 4 703M 4 912M 4 700M 4 795M 3 915M 2 899M
totalLiabilitiesAndStockholdersEquity 9 708M 9 879M 9 988M 10 046M 10 830M 11 147M 10 205M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 9 708M 9 753M 9 879M 9 988M 10 046M 10 782M 10 830M 11 147M 10 205M 10 507M 9 112M 7 777M
totalInvestments 0 47M 85M 76M -3 776M -4 074M 0 28M 64M 122M 109M -3 409M
totalDebt 4 947M 4 918M 4 990M 5 014M 4 946M 4 849M 4 849M 4 865M 4 217M 4 202M 3 241M 3 018M
netDebt 4 612M 4 629M 4 828M 4 785M 4 737M 4 569M 4 597M 4 423M 3 936M 3 753M 2 345M 2 065M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-10-25 2023-12-08 2023-06-12 2021-08-30 2020-08-31
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 1 506M 1 401M 1 449M 1 193M 900M
otherReceivables 60M 38M 48M 50M 19M
prepaids 91M 130M 88M 68M 44M
totalPayables 377M 468M 471M 415M 326M
otherPayables 16M 44M 50M 30M 5M
accruedExpenses 162M 160M 198M 184M 141M
capitalLeaseObligationsCurrent 13M 11M 14M 16M 15M
capitalLeaseObligationsNonCurrent 0 0 0 0 0
treasuryStock 0 0 0 0 -607M
additionalPaidInCapital 4 787M 4 701M 4 649M 4 205M 3 818M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2 2021 q2 2020 q2
date 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2021-06-30 2020-06-30
symbol CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT CTLT
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
fillingDate 2024-11-05 2024-05-08 2024-02-14 2023-12-08 2023-06-12 2023-02-07 2022-11-01
acceptedDate 2024-11-05 16:01:06 2024-10-25 16:41:33 2024-05-08 16:23:50 2024-02-14 14:23:55 2023-12-08 17:06:39 2023-12-08 17:05:20 2023-06-12 16:08:27 2023-02-07 09:26:06 2022-11-01 09:16:12 2023-06-12 15:58:53 2021-08-30 09:26:48 2020-08-31 16:28:27
calendarYear 2025 2024 2024 2024 2023 2023 2023
period Q1 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY FY FY
netIncome -129M -1 043M -101M -206M -759M -256M -227M 81M -2M 519M 585M 221M
depreciationAndAmortization 113M 489M 126M 121M 112M 422M 106M 103M 99M 378M 289M 254M
deferredIncomeTax -5M -28M 3M 17M -44M -127M -82M 17M -4M 14M 64M 2M
stockBasedCompensation 17M 68M 17M 16M 19M 35M 6M 10M 19M 54M 51M 48M
changeInWorkingCapital 46M -62M -101M 101M 56M -160M -120M -20M -261M -612M -432M -121M
accountsReceivables 173M 79M -35M 5M 160M 53M -130M 117M 31M -73M -186M -151M
inventory -10M 109M -15M -15M -31M -192M 45M -95M -85M -128M -260M -76M
accountsPayables -10M -84M -18M 33M -73M -21M 29M -16M -52M 37M 50M 72M
otherWorkingCapital -107M -166M -33M 78M -56M 160M -64M -26M -155M -448M -36M 34M
otherNonCashItems 19M 844M 4M 63M 546M 347M 253M 23M 57M 86M -124M 37M
netCashProvidedByOperatingActivities 61M 268M 12M 112M -70M 261M -64M 214M -92M 439M 433M 440M
investmentsInPropertyPlantAndEquipment -57M -327M -74M -94M -84M -583M -138M -168M -149M -660M -686M -466M
acquisitionsNet 23M 0 0 0 1 000 000 -474M 0 -474M 0 -1 202M 140M -359M
purchasesOfInvestments 0 -1 000 000 0 -1 000 000 -1 000 000 -2M -1 000 000 0 0 -22M -103M -3M
salesMaturitiesOfInvestments 0 0 0 0 -1 000 000 89M 28M 34M 27M 665M 430M 448M
otherInvestingActivites 0 0 -1 000 000 1 000 000 1 000 000 0 6M
netCashUsedForInvestingActivites -34M -74M -95M -84M -110M -608M -116M
debtRepayment -5M -245M -2M -35M -144M -25M -7M
commonStockIssued 1 000 000 8M 0 1 000 000 0 0 0
commonStockRepurchased 0 0 0 0 0 0 0 0 0 -10M 0 0
dividendsPaid 0 0 0 0 0 0 0
otherFinancingActivites -6M -253M -12M 132M 119M 548M 81M
netCashUsedProvidedByFinancingActivities -10M 0 -14M 98M -25M 523M 74M
effectOfForexChangesOnCash 29M -6M -5M 17M -15M 11M 9M 32M -34M -33M 17M -7M
netChangeInCash 46M 9M -67M 20M -71M -169M -190M 161M -168M -447M -57M 608M
cashAtEndOfPeriod 335M 289M 162M 229M 209M 280M 252M 442M 281M 449M 896M 953M
cashAtBeginningOfPeriod 289M 280M 229M 209M 280M 449M 442M 281M 449M 896M 953M 345M
operatingCashFlow 61M 268M 12M 112M -70M 261M -64M 214M -92M 439M 433M 440M
capitalExpenditure -57M -327M -74M -94M -84M -583M -138M -168M -149M -660M -686M -466M
freeCashFlow 4M -59M -62M 18M -154M -322M -202M 46M -241M -221M -253M -26M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link
filingDate 2024-10-25 2023-12-08 2023-06-12 2021-08-30 2020-08-31
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 1 000 000 8M -665M -430M -448M
netCashProvidedByInvestingActivities -327M -962M -1 884M -649M -828M
netDebtIssuance 84M 485M 1 022M 99M 23M
longTermNetDebtIssuance 84M 485M 1 022M 99M 73M
shortTermNetDebtIssuance 0 0 0 0 -886M
netStockIssuance 9M 0 0 120M 1 046M
netCommonStockIssuance 9M 0 0 82M 1 046M
commonStockIssuance 9M 4M 362M 82M 1 047M
netPreferredStockIssuance 0 0 0 38M 0
netDividendsPaid 0 0 -4M -22M -36M
commonDividendsPaid 0 0 -4M -22M 0
preferredDividendsPaid 0 0 0 0 -36M
otherFinancingActivities -19M 36M 13M -55M -31M
netCashProvidedByFinancingActivities 74M 521M 1 031M 142M 1 002M
incomeTaxesPaid 43M 99M 53M 47M 43M
interestPaid 226M 188M 116M 105M 98M

Earning call transcript

2023 q3
2023-11-15 ET (fiscal 2024 q1)
2023 q2
2023-08-29 ET (fiscal 2023 q4)
2023 q1
2023-05-19 ET (fiscal 2023 q3)
2022 q4
2023-02-07 ET (fiscal 2023 q2)
2022 q3
2022-11-01 ET (fiscal 2023 q1)
2022 q2
2022-08-29 ET (fiscal 2022 q4)
2022 q1
2022-05-03 ET (fiscal 2022 q3)
2021 q4
2022-02-02 ET (fiscal 2022 q2)

SEC forms

Show financial reports only

SEC form 10
2024-11-05 16:01 ET
Catalent published news for 2024 q3
SEC form 8
2024-11-05 07:10 ET
Catalent reported for 2024 q3
SEC form 8
2024-11-05 07:10 ET
Catalent published news for 2024 q3
SEC form 10
2024-09-06 00:00 ET
Catalent reported for 2024 q2
SEC form 8
2024-08-29 07:47 ET
Catalent published news for 2024 q2
SEC form 8
2024-08-29 07:47 ET
Catalent published news for 2024 q2
SEC form 10
2024-05-08 16:23 ET
Catalent published news for 2024 q1
SEC form 8
2024-05-08 00:00 ET
Catalent reported for 2024 q1
SEC form 8
2024-05-08 00:00 ET
Catalent published news for 2024 q1
SEC form 10
2024-05-08 00:00 ET
Catalent reported for 2024 q1
SEC form 10
2024-02-14 00:00 ET
Catalent reported for 2023 q4
SEC form 8
2024-02-09 00:00 ET
Catalent reported for 2023 q4
SEC form 8
2024-02-09 00:00 ET
Catalent published news for 2023 q4
SEC form 10
2023-12-08 00:00 ET
Catalent reported for 2023 q2
SEC form 10
2023-12-08 00:00 ET
Catalent reported for 2023 q3
SEC form 8
2023-11-15 07:05 ET
Catalent reported for 2023 q3
SEC form 8
2023-08-29 00:00 ET
Catalent reported for 2023 q2
SEC form 6
2023-07-07 16:26 ET
Catalent published news for 2023 q2
SEC form 10
2023-06-12 16:08 ET
Catalent reported for 2023 q1
SEC form 6
2023-06-12 15:58 ET
Catalent published news for 2023 q1
SEC form 6
2023-06-12 07:12 ET
Catalent reported for 2023 q1
SEC form 10
2023-06-12 00:00 ET
Catalent published news for 2023 q1
SEC form 8
2023-06-12 00:00 ET
Catalent published news for 2023 q1
SEC form 6
2023-05-19 08:00 ET
Catalent published news for 2023 q1
SEC form 8
2023-05-19 00:00 ET
Catalent published news for 2023 q1
SEC form 6
2023-05-12 21:14 ET
Catalent published news for 2023 q1
SEC form 6
2023-05-11 17:03 ET
Catalent published news for 2023 q1
SEC form 6
2023-05-08 08:02 ET
Catalent published news for 2023 q1
SEC form 8
2023-05-08 00:00 ET
Catalent published news for 2023 q1
SEC form 6
2023-04-14 07:53 ET
Catalent published news for 2023 q1
SEC form 8
2023-04-14 00:00 ET
Catalent published news for 2023 q1
SEC form 6
2023-02-21 10:10 ET
Catalent published news for 2022 q4
SEC form 10
2023-02-07 09:26 ET
Catalent published news for 2022 q4
SEC form 6
2023-02-07 07:05 ET
Catalent published news for 2022 q4
SEC form 10
2023-02-07 00:00 ET
Catalent reported for 2022 q4
SEC form 8
2023-02-07 00:00 ET
Catalent reported for 2022 q4
SEC form 6
2023-02-06 19:20 ET
Catalent published news for 2022 q4
SEC form 6
2022-12-19 08:14 ET
Catalent published news for 2022 q3
SEC form 6
2022-11-22 16:37 ET
Catalent published news for 2022 q3
SEC form 10
2022-11-01 09:16 ET
Catalent published news for 2022 q3
SEC form 6
2022-11-01 07:04 ET
Catalent published news for 2022 q3
SEC form 10
2022-11-01 00:00 ET
Catalent reported for 2022 q3
SEC form 8
2022-11-01 00:00 ET
Catalent reported for 2022 q3
SEC form 6
2022-09-23 16:05 ET
Catalent published news for 2022 q2
SEC form 6
2022-09-19 16:41 ET
Catalent published news for 2022 q2
SEC form 6
2022-09-16 08:01 ET
Catalent published news for 2022 q2
SEC form 10
2022-08-29 09:21 ET
Catalent published news for 2022 q2
SEC form 6
2022-08-29 07:04 ET
Catalent published news for 2022 q2
SEC form 10
2022-08-29 00:00 ET
Catalent reported for 2022 q2
SEC form 8
2022-08-29 00:00 ET
Catalent reported for 2022 q2
SEC form 6
2022-07-05 08:37 ET
Catalent published news for 2022 q2
SEC form 10
2022-05-03 09:08 ET
Catalent published news for 2022 q1
SEC form 6
2022-05-03 07:48 ET
Catalent published news for 2022 q1
SEC form 10
2022-05-03 00:00 ET
Catalent reported for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Catalent reported for 2022 q1
SEC form 10
2022-02-01 09:17 ET
Catalent published news for 2021 q4
SEC form 6
2022-02-01 07:05 ET
Catalent published news for 2021 q4
SEC form 10
2022-02-01 00:00 ET
Catalent published news for 2021 q4
SEC form 8
2022-02-01 00:00 ET
Catalent published news for 2021 q4
SEC form 6
2022-01-05 08:15 ET
Catalent published news for 2021 q4
SEC form 10
2021-11-02 09:11 ET
Catalent published news for 2021 q3
SEC form 6
2021-11-02 07:10 ET
Catalent published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
Catalent published news for 2021 q3
SEC form 10
2021-11-02 00:00 ET
Catalent published news for 2021 q3
SEC form 6
2021-09-29 16:32 ET
Catalent published news for 2021 q2
SEC form 6
2021-09-23 19:06 ET
Catalent published news for 2021 q2
SEC form 6
2021-09-23 07:54 ET
Catalent published news for 2021 q2
SEC form 6
2021-09-17 07:31 ET
Catalent published news for 2021 q2
SEC form 6
2021-09-03 16:41 ET
Catalent published news for 2021 q2
SEC form 10
2021-08-30 09:26 ET
Catalent published news for 2021 q2
SEC form 6
2021-08-30 07:15 ET
Catalent published news for 2021 q2
SEC form 8
2021-08-30 00:00 ET
Catalent published news for 2021 q2
SEC form 10
2021-08-30 00:00 ET
Catalent published news for 2021 q2
SEC form 6
2021-05-20 16:33 ET
Catalent published news for 2021 q1
SEC form 6
2021-05-11 07:30 ET
Catalent published news for 2021 q1
SEC form 10
2021-05-04 09:03 ET
Catalent published news for 2021 q1
SEC form 6
2021-05-04 07:07 ET
Catalent published news for 2021 q1
SEC form 10
2021-05-04 00:00 ET
Catalent published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
Catalent published news for 2021 q1
SEC form 6
2021-02-22 16:27 ET
Catalent published news for 2020 q4
SEC form 6
2021-02-10 17:29 ET
Catalent published news for 2020 q4
SEC form 6
2021-02-10 07:50 ET
Catalent published news for 2020 q4
SEC form 10
2021-02-02 08:15 ET
Catalent published news for 2020 q4
SEC form 6
2021-02-02 07:21 ET
Catalent published news for 2020 q4
SEC form 10
2020-11-03 08:10 ET
Catalent published news for 2020 q3
SEC form 6
2020-11-03 07:13 ET
Catalent published news for 2020 q3
SEC form 6
2020-09-18 07:30 ET
Catalent published news for 2020 q2